Company Profile
Insilico Medicine
Headquarters
Hong Kong, China
Year Founded
2014
Top Impacted Industries
Pharmaceuticals, Biotechnology, Drug Discovery, Life Sciences, Healthcare
About Us
Insilico Medicine develops generative AI technology for end-to-end drug discovery and development. Its Pharma.AI platform combines AI-driven target discovery, molecular design, biomarker research, clinical trial analysis, and laboratory automation to advance potential therapies across areas including cancer, fibrosis, immunology, and aging-related diseases.
Related Articles
Trending Companies
Latest Articles
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2026 All Rights Reserved.